Salagianni, Maria;Andreakos, Evangelos;Biomedical Research Foundation of the Academy of Athens
发明人:
申请号：
EP17161461.3
公开号：
EP3375452A1
申请日:
2017.03.16
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The invention relates to the field of treatment or prevention of obesity-related disorders, atherosclerosis or a coagulation disorder. In particular, the present invention relates to the use of an activator of IFNλ receptor for the treatment or prevention of such disorders or conditions, and corresponding methods of treatment.
